tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market
Advertisement

Cipher Pharmaceuticals (CPH) Ratios

Compare
84 Followers

Cipher Pharmaceuticals Ratios

TSE:CPH's free cash flow for Q4 2024 was $0.57. For the 2024 fiscal year, TSE:CPH's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.94 9.19 4.07 2.39 2.03
Quick Ratio
1.64 8.62 3.84 2.25 1.94
Cash Ratio
0.90 7.58 3.08 1.67 0.92
Solvency Ratio
0.25 3.92 2.85 0.66 0.49
Operating Cash Flow Ratio
0.98 3.05 1.13 1.12 1.18
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -21.68M$ 42.76M$ 28.46M$ 16.57M$ 8.49M
Leverage Ratios
Debt-to-Assets Ratio
0.25 <0.01 <0.01 <0.01 0.04
Debt-to-Equity Ratio
0.40 <0.01 <0.01 0.01 0.06
Debt-to-Capital Ratio
0.28 <0.01 <0.01 0.01 0.05
Long-Term Debt-to-Capital Ratio
0.28 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.59 1.07 1.15 1.33 1.36
Debt Service Coverage Ratio
0.00 0.00 58.42 112.59 34.83
Interest Coverage Ratio
0.00 0.00 23.89 128.49 37.76
Debt to Market Cap
0.17 0.00 0.00 0.00 0.00
Interest Debt Per Share
1.58 0.01 <0.01 0.02 0.08
Net Debt to EBITDA
1.77 -3.42 -2.38 -1.47 -0.54
Profitability Margins
Gross Profit Margin
71.95%80.77%80.69%83.21%85.85%
EBIT Margin
18.39%48.68%53.45%59.51%56.30%
EBITDA Margin
32.44%54.48%57.80%62.25%62.02%
Operating Profit Margin
24.00%54.48%53.62%53.87%56.44%
Pretax Profit Margin
4.74%59.92%55.52%50.40%30.25%
Net Profit Margin
23.40%96.32%128.83%35.36%21.05%
Continuous Operations Profit Margin
23.40%96.32%128.83%35.36%20.30%
Net Income Per EBT
493.38%160.74%232.04%70.15%69.60%
EBT Per EBIT
19.76%109.99%103.55%93.55%53.59%
Return on Assets (ROA)
5.69%23.69%36.10%15.02%10.27%
Return on Equity (ROE)
9.85%25.31%41.57%19.94%13.94%
Return on Capital Employed (ROCE)
6.65%14.27%17.21%30.04%35.50%
Return on Invested Capital (ROIC)
32.74%22.91%39.87%21.04%23.72%
Return on Tangible Assets
13.94%29.73%48.15%24.02%18.65%
Earnings Yield
3.91%19.15%8.75%20.84%23.06%
Efficiency Ratios
Receivables Turnover
2.85 4.16 3.04 3.30 2.34
Payables Turnover
1.89 0.88 0.97 0.66 1.86
Inventory Turnover
1.91 1.36 1.86 2.23 3.43
Fixed Asset Turnover
58.11 52.64 42.98 43.80 11.33
Asset Turnover
0.24 0.25 0.28 0.42 0.49
Working Capital Turnover Ratio
2.38 0.59 0.90 1.61 3.99
Cash Conversion Cycle
125.36 -60.88 -58.67 -276.15 65.84
Days of Sales Outstanding
128.02 87.76 120.08 110.75 155.75
Days of Inventory Outstanding
190.73 267.49 196.76 163.48 106.50
Days of Payables Outstanding
193.40 416.13 375.51 550.37 196.41
Operating Cycle
318.76 355.25 316.85 274.23 262.25
Cash Flow Ratios
Operating Cash Flow Per Share
0.76 0.63 0.10 0.52 0.43
Free Cash Flow Per Share
0.76 0.63 0.10 0.52 0.40
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.03
Free Cash Flow to Operating Cash Flow
1.00 1.00 0.99 1.00 0.93
Dividend Paid and CapEx Coverage Ratio
444.23 111.10 130.56 0.00 15.38
Capital Expenditure Coverage Ratio
444.23 111.10 130.56 0.00 15.38
Operating Cash Flow Coverage Ratio
0.48 45.32 24.71 26.77 6.32
Operating Cash Flow to Sales Ratio
0.49 0.76 0.51 0.63 0.54
Free Cash Flow Yield
8.24%15.01%3.45%37.11%55.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.63 5.22 11.43 4.80 4.34
Price-to-Sales (P/S) Ratio
6.00 5.03 14.73 1.70 0.91
Price-to-Book (P/B) Ratio
2.32 1.32 4.75 0.96 0.60
Price-to-Free Cash Flow (P/FCF) Ratio
12.15 6.66 29.01 2.69 1.80
Price-to-Operating Cash Flow Ratio
12.12 6.65 28.79 2.69 1.69
Price-to-Earnings Growth (PEG) Ratio
-1.09 0.02 -0.83 0.07 0.10
Price-to-Fair Value
2.32 1.32 4.75 0.96 0.60
Enterprise Value Multiple
20.27 5.81 23.10 1.26 0.93
Enterprise Value
259.53M 66.94M 276.07M 17.19M 12.43M
EV to EBITDA
20.25 5.81 23.10 1.26 0.93
EV to Sales
6.57 3.16 13.35 0.78 0.58
EV to Free Cash Flow
13.31 4.19 26.31 1.24 1.14
EV to Operating Cash Flow
13.28 4.18 26.11 1.24 1.06
Tangible Book Value Per Share
0.24 2.47 0.42 0.73 0.47
Shareholders’ Equity Per Share
4.00 3.16 0.60 1.46 1.21
Tax and Other Ratios
Effective Tax Rate
-3.93 -0.61 -1.32 0.30 0.33
Revenue Per Share
1.54 0.83 0.19 0.82 0.80
Net Income Per Share
0.36 0.80 0.25 0.29 0.17
Tax Burden
4.93 1.61 2.32 0.70 0.70
Interest Burden
0.26 1.23 1.04 0.85 0.54
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.33 0.25 0.21 0.00 0.00
Stock-Based Compensation to Revenue
0.03 0.06 0.02 <0.01 <0.01
Income Quality
1.69 0.78 0.40 1.78 2.67
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis